Integral’s strategy centers on capitalizing on the growing demand for diagnostic imaging. Volume growth is driven by population growth, ageing demographics, higher incidence of diseases, and wider adoption of preventative diagnostics. These drivers are often greater in regional areas which Integral focuses on.
Earnings are defensive driven by demographic factors and wider adoption of preventative diagnostics.
Barriers to entry are relatively low and Integral has no discernible intangible assets that are unique, exclusive, or irreplicable.
|
Metric
|
IDX
|
HLS
|
SHL
|
|---|---|---|---|
Price/Earnings (Normalized) | 28.23 | 2.52 | 25.05 |
Price/Book Value | 1.90 | 0.88 | 1.67 |
Price/Sales | 1.26 | 0.46 | 1.53 |
Price/Cash Flow | 9.28 | 2.72 | 11.25 |
|
Metric
|
IDX
|
HLS
|
SHL
|
|---|---|---|---|
Quick Ratio | 0.47 | 0.44 | 0.78 |
Current Ratio | 0.76 | 0.53 | 0.94 |
Interest Coverage | −1.55 | −13.26 | 5.95 |
|
Metric
|
IDX
|
HLS
|
SHL
|
|---|---|---|---|
Return on Assets (Normalized) | −0.84% | 0.10% | 4.07% |
Return on Equity (Normalized) | −1.95% | 0.23% | 7.01% |
Return on Invested Capital (Normalized) | 1.08% | 2.27% | 4.52% |
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Zhhrjjchw | Qxxy | $220.6 Bil | |
DHR
| Danaher Corp | Gxyhcypj | Xhppbm | $184.8 Bil | |
A
| Agilent Technologies Inc | Vgslxhnwkd | Rcxnv | $43.9 Bil | |
IQV
| IQVIA Holdings Inc | Nmkzlyjf | Nspgl | $42.6 Bil | |
IDXX
| IDEXX Laboratories Inc | Pxbdjchvd | Qlfljwt | $42.1 Bil | |
MTD
| Mettler-Toledo International Inc | Pcpyxxzrn | Bdvrmx | $32.3 Bil | |
ICLR
| Icon PLC | Kxtllnwt | Kdxlt | $26.1 Bil | |
WAT
| Waters Corp | Zswhwtvpn | Dqyns | $20.8 Bil | |
ILMN
| Illumina Inc | Jffbgts | Fypchn | $17.6 Bil | |
LH
| Laboratory Corp of America Holdings | Tnfzpmpwxh | Xjdlws | $17.4 Bil |
